Literature DB >> 30527422

Leptin levels predict the development of insulin resistance in a sample of adult men-The Olivetti Heart Study.

L D'Elia1, P Strazzullo1, R Iacone1, O Russo1, F Galletti2.   

Abstract

BACKGROUND AND AIMS: Leptin (LPT) is associated with unfavourable cardio-metabolic risk profile. Although a number of studies have found a positive association between LPT and insulin resistance (IR), no observational study has evaluated a prospective association to detect a predictive role of LPT in IR. Therefore, the aim of this study was to estimate the role of LPT on the incidence of IR in an 8-year follow-up of a sample of adult men (The Olivetti Heart Study). METHODS AND
RESULTS: The study included 527 not diabetic men without IR (homeostasis model assessment - HOMA index < 2.77 UI) at baseline. Baseline LPT was significantly and positively associated with HOMA index, body mass index (BMI), waist circumference and blood pressure. At the end of the 8-year follow-up period, a positive and significant association was detected between baseline LPT and changes in HOMA index (r = 0.25, p < 0.01) and incidence of IR (OR: 2.6, 95%CI: 1.9-3.4). This trend was also confirmed after adjustment for potential confounders. In addition, the predictive value of LPT was found in subjects who had not experienced any weight increase over the years, and for normal weight and excess body weight participants, separately.
CONCLUSIONS: The results of this prospective study suggest a predictive role of circulating LPT levels on a reduction of insulin sensitivity over time, independently of main potential confounders, in non-diabetic men without IR at baseline. In addition, in normal weight individuals, LPT levels were associated with development of IR.
Copyright © 2018 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adipocytokines; Adipokines; HOMA index; Insulin resistance; Leptin

Mesh:

Substances:

Year:  2018        PMID: 30527422     DOI: 10.1016/j.numecd.2018.10.003

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  5 in total

1.  Circulating leptin is associated with serum uric acid level and its tubular reabsorption in a sample of adult middle-aged men.

Authors:  L D'Elia; A Giaquinto; F P Cappuccio; R Iacone; O Russo; P Strazzullo; F Galletti
Journal:  J Endocrinol Invest       Date:  2019-11-05       Impact factor: 4.256

2.  Association of serum leptin with angiographically proven cardiovascular disease and with components of the metabolic syndrome: a cross-sectional study in East Azerbaijan.

Authors:  Nafiseh Khanbabaei; Hossein Mozafar Saadati; Shahnam Valizadeh Shahbazloo; Reyhaneh Hoseinpoor; Seyed Hossein Naderi; Roya Taghvamanesh; Sakhavat Abolhasani
Journal:  Cardiovasc Endocrinol Metab       Date:  2020-08-13

Review 3.  How the love of muscle can break a heart: Impact of anabolic androgenic steroids on skeletal muscle hypertrophy, metabolic and cardiovascular health.

Authors:  Deaglan McCullough; Richard Webb; Kevin J Enright; Katie E Lane; Jim McVeigh; Claire E Stewart; Ian G Davies
Journal:  Rev Endocr Metab Disord       Date:  2020-12-02       Impact factor: 6.514

4.  Cytokines, Adipokines, and Bone Markers at Rest and in Response to Plyometric Exercise in Obese vs Normal Weight Adolescent Females.

Authors:  Nigel Kurgan; Katherine McKee; Melissa Calleja; Andrea R Josse; Panagiota Klentrou
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-11       Impact factor: 5.555

5.  Serum leptin is associated with increased pulse pressure and the development of arterial stiffening in adult men: results of an eight-year follow-up study.

Authors:  Lanfranco D'Elia; Alfonso Giaquinto; Roberto Iacone; Ornella Russo; Pasquale Strazzullo; Ferruccio Galletti
Journal:  Hypertens Res       Date:  2021-08-12       Impact factor: 3.872

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.